O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
about
Brain tumorsNewer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overviewMalignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsA Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft ModelTargeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging GliomasImaging tumor metabolism using positron emission tomographyMolecular and functional imaging technology for the development of efficient treatment strategies for gliomas.Imaging biomarkers in primary brain tumours.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.Diagnostics of cerebral gliomas with radiolabeled amino acids.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.Molecular imaging of gliomas with PET: opportunities and limitations.Radiosyntheses using fluorine-18: the art and science of late stage fluorinationRadiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETComparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesionsRadiosynthesis and biological evaluation of N-[18F]labeled glutamic acid as a tumor metabolic imaging tracerFrom the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Novel Approaches to Imaging Tumor MetabolismThe Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PETSerial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant gliomaContribution of (18)F-Fluoro-ethyl-tyrosine Positron Emission Tomography to Target Volume Delineation in Stereotactic Radiotherapy of Malignant Cranial Base Tumours: First Clinical ExperienceSynthesis and Biological Evaluation of (S)-Amino-2-methyl-4-[(76)Br]bromo-3-(E)-butenoic Acid (BrVAIB) for Brain Tumor Imaging.Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imagingPositron detection for the intraoperative localisation of cancer deposits18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity.[(18)F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients - A Review.Endogenous compounds labeled with radionuclides of short half-life-some perspectives.Radiotherapy to volumes defined by metabolic imaging in gliomas: time to abandon monstrous margins?Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.PET tracer development--a tale of mice and men.Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction.
P2860
Q24605136-6E4A5AD0-9421-44E9-8746-2B79427EA866Q26767172-8CCE5AEC-16B0-4331-93ED-0DF25E6E9252Q26853516-7B49A178-4402-410E-AB56-FA3A6163AE5AQ27324332-C5C86F95-3DC2-498C-B347-4C90C74906DEQ27335251-785A29D4-E979-44DE-9E9A-506634443FF9Q28085278-E4587DB8-2BB0-48D9-B367-E159A527BA8EQ30775012-8B23EEA9-0B51-4A17-850D-E0C97734DC7CQ30880129-1683F4A5-AB01-40DB-9607-0E3F9A0A25BFQ30907831-79ACC6E4-0DE3-46D5-B07A-E02B0013C245Q31156299-E37D1F45-C30B-4CFF-B9A1-7FEF538C4903Q33395877-F65E40E2-B58E-4FCD-AAA4-A6A543C80B55Q33487194-BC88FC21-C625-4EDF-94F2-49CBB1C96BD4Q33578187-859079AE-DCE9-41BC-B6DA-EBCED3C0A013Q33746805-92A1779B-1BA6-4921-BE01-15FC78A37724Q33961188-41756AB6-E6A3-46C8-A0A0-C276AD4C2920Q34074437-ED89C4CB-B2E0-4712-96A5-9FB548C3A16DQ34235986-D4899CAE-EF4B-4FC5-81E3-084F0155BFADQ34348544-2F4F759E-C404-4932-A72A-B7A35063A949Q34498995-C3217AB4-EA32-4BF3-9384-7B088ADEBDABQ35093266-C89EC83F-4EF7-4954-B64D-1EDF05F14A5CQ35134961-B72FBB36-90DB-4FF4-A712-36DB862A025BQ35679377-0D92872E-EF73-4F90-A28A-A14C43A3CB5FQ35700192-9CEC08B1-E5C1-4A1E-86F0-AAF0E6A10F0FQ35807945-E0D9713D-5EA3-4607-8091-3762BE3CB33AQ36021392-F569519B-FC09-4520-8EE8-106929526A12Q36413724-806176C6-A35D-4D94-A92B-9901708469C4Q36609872-FA18CDEE-D8F4-4ACF-B79A-863BE5359152Q36816606-9DAD59CB-00DB-47AA-A242-A017A8C267D0Q36925038-B616E9A4-60A4-4205-B8BB-6F47EAD1CCB8Q37155873-3EA705C2-C884-4AFF-ABB4-BBDE78BE966DQ37236103-7AB50C84-742F-4B04-A2BB-624E47110B1DQ37432387-DD3C2B7F-A45A-4D6B-929A-9D61EEE91DC4Q37580486-5636B029-CBC4-4117-A634-4CDF49591BE4Q38036587-F1CC8AB6-7251-46E1-8BD2-958BC9D4AF68Q38102999-B42CB8E5-81F3-41E7-912F-965F043EF710Q38166981-A5E87DE5-F62A-4ACB-AA4E-59784D2EDCB5Q38254032-C5BAA956-BB2F-40CF-830C-D972D72CB6DFQ38815396-7DCE70E7-ADFF-4FCB-9DD3-8A5C311E2A8CQ40268582-BBEFA56E-4A1A-47BD-9187-1DFB5AF845CFQ41212276-B81CA23F-760E-4E85-971F-0BB43F733B11
P2860
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
O-(2-[18F]fluoroethyl)-L-tyros ...... esults of a comparative study.
@ast
O-(2-[18F]fluoroethyl)-L-tyros ...... esults of a comparative study.
@en
type
label
O-(2-[18F]fluoroethyl)-L-tyros ...... esults of a comparative study.
@ast
O-(2-[18F]fluoroethyl)-L-tyros ...... esults of a comparative study.
@en
prefLabel
O-(2-[18F]fluoroethyl)-L-tyros ...... esults of a comparative study.
@ast
O-(2-[18F]fluoroethyl)-L-tyros ...... esults of a comparative study.
@en
P2093
P356
P1476
O-(2-[18F]fluoroethyl)-L-tyros ...... esults of a comparative study.
@en
P2093
Feldmann HJ
Schwaiger M
Stöcklin G
P2888
P304
P356
10.1007/S002590050541
P577
2000-05-01T00:00:00Z
P6179
1001267727